McPherson J M, Sawamura S, Armstrong R
J Biomed Mater Res. 1986 Jan;20(1):93-107. doi: 10.1002/jbm.820200109.
The biologic response to injectable, glutaraldehyde cross-linked, fibrillar collagen implants in the rat subcutaneous model was shown to be a function of the concentration of glutaraldehyde used for cross-linking. The collagen was prepared from bovine hide by pepsin solubilization and reconstituted as a fibrillar suspension of 35 mg collagen/mL. Fibrillar collagen implants cross-linked with glutaraldehyde concentrations equal to or less than 0.01% exhibited a response characterized by fibroblast invasion, neovascularization and little, if any, evidence of inflammation. Implants cross-linked with 0.1 and 1.0% glutaraldehyde elicited a foreign body/giant cell reaction and varying degrees of implant erosion. The interaction of human skin fibroblasts with 0.01% glutaraldehyde cross-linked collagen in vitro was found to be dependent on the culture conditions utilized to evaluate the interaction. When the ratio of cell culture media to collagen was 20:1, cell invasion of the cross-linked preparations was observed, whereas, when this ratio was reduced to 1:1, such interactions could not be detected. Noncross-linked preparations were colonized by cells regardless of the experimental conditions used. Studies of implants in both the rat and guinea pig subcutaneous models indicated that glutaraldehyde cross-linking concentrations as low as 0.0075% provided enhanced wet weight recovery (wet weight persistence) and resistance to biologic degradation (collagen persistence) as compared to noncross-linked fibrillar collagen preparations. These cross-linked implants also exhibited a greater degree of fibroblast infiltration and vascularization. Between 30 and 60 days, some degree of calcification developed in both collagen formulations implanted in rats and guinea pigs; however, the reaction occurred with greater frequency and intensity in cross-linked preparations in guinea pigs. Calcification in the guinea pig was followed by the appearance of focal areas of ossification.
在大鼠皮下模型中,对可注射的、经戊二醛交联的纤维状胶原蛋白植入物的生物学反应显示为用于交联的戊二醛浓度的函数。胶原蛋白由牛皮经胃蛋白酶溶解制备,并重构为浓度为35 mg胶原蛋白/mL的纤维状悬浮液。用浓度等于或小于0.01%的戊二醛交联的纤维状胶原蛋白植入物表现出以成纤维细胞侵入、新血管形成且几乎没有(如果有的话)炎症迹象为特征的反应。用0.1%和1.0%戊二醛交联的植入物引发异物/巨细胞反应以及不同程度的植入物侵蚀。发现人皮肤成纤维细胞与0.01%戊二醛交联的胶原蛋白在体外的相互作用取决于用于评估相互作用的培养条件。当细胞培养基与胶原蛋白的比例为20:1时,观察到交联制剂的细胞侵入,而当该比例降至1:1时,无法检测到这种相互作用。无论使用何种实验条件,未交联的制剂都会被细胞定植。在大鼠和豚鼠皮下模型中对植入物的研究表明,与未交联的纤维状胶原蛋白制剂相比,低至0.0075%的戊二醛交联浓度可提高湿重恢复(湿重持久性)和对生物降解的抵抗力(胶原蛋白持久性)。这些交联植入物还表现出更大程度的成纤维细胞浸润和血管形成。在30至60天之间,植入大鼠和豚鼠的两种胶原蛋白制剂中均出现了一定程度的钙化;然而,这种反应在豚鼠的交联制剂中出现的频率和强度更高。豚鼠中的钙化之后出现了局部骨化区域。